A client with immune thrombocytopenic purpura (ITP) will begin treatment with romiplostim (Nplate) to be administered by subcutaneous injection in the provider's office once per week. Which statement should the nurse plan to include when educating the client about this medication?

D This medication stimulates the bone marrow to increase platelet production. A This medication increases the production of plasma enzyme ADAMTS-13. C This medication prevents platelets from binding with heparin. B This medication prevents platelets from being destroyed in the spleen.